A new clinical trial underway in the Lowcountry is drawing attention for its unconventional — and potentially groundbreaking ...

Your skeleton is 20 pounds of miracle, contributing to your mood, memory, and metabolism. Learn why better mental health may, ...

Lipocine ( ($LPCN) ) has shared an announcement. On December 16, 2025, Lipocine announced that its Phase 3 clinical trial for LPCN 1154, an oral ...

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said the FDA has received its Abbreviated New Drug Application for KETAFREE (TM), a preservative-free intravenous ...

- Using Ascletis' proprietary Ultra-Long-Acting Platform technology, co-formulation of ASC36, a once-monthly subcutaneously administered amylin receptor peptide agonist and ASC35, a once-monthly ...

Is your client depressed or just grieving? Advisors often wrestle with this question as they sit across the table from someone who has recently lost a spouse, parent or child. You may see tears, hear ...

MTS-004 Poised to Fill an Unmet Need in the Treatment of Pseudobulbar Affect (PBA) BEIJING, China, Oct. 23, 2025 /PRNewswire/ -- METiS TechBio, a global leader in AI-driven nanodelivery and ...

Tens of millions of people with depression aren't properly diagnosed. Stanford researchers show that brain imaging could revolutionize treatment. Researchers at Stanford recently described six ...

From mood trackers to guided cognitive-behavioral therapy (CBT) and peer support, depression apps are crowding the digital marketplace. As more patients turn to this technology to ease their symptoms, ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Non-Commercial (NC): Only non-commercial uses of the work are permitted. Major ...

The FDA designation expands the drug’s potential patient pool tenfold, to an estimated 13 million Americans who consider suicide annually. Clinical trials demonstrated rapid and statistically ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The FDA designation expands the drug’s ...